Related by context. All words. (Click for frequent words.) 74 BLA filing 72 GLP toxicology studies 72 Phase Ib study 72 PMA submission 71 IND Investigational New 71 IND enabling 70 IMA# 70 preclinical toxicology 69 BLA submission 69 MAA submission 69 Phase 2a clinical trials 69 NDA resubmission 69 PANVAC VF 68 Phase 2a trial 68 phase IIa clinical 68 pivotal bioequivalence 68 CRMD# 68 registrational 68 DPX Survivac 68 Phase 2b study 67 oral prodrug 67 sNDA submission 67 PLK1 SNALP 67 Phase IIa trial 67 Surfaxin LS 67 Phase Ib II 67 phase IIb trial 67 HGS# 67 PDE4 inhibitor 67 Phase #b/#a 67 Phase IIb trials 67 Phase IIb clinical trials 67 IIa trial 67 NDA submission 67 midstage trials 67 DXL# 67 phase IIb clinical 66 Phase IIa trials 66 cannabinor 66 lucinactant 66 Allovectin 7 66 Exherin TM 66 Troxatyl 66 GSK# [002] 66 PSN# [002] 66 SUCCEED trial 66 TOCOSOL Paclitaxel 66 Civacir 66 NEBIDO 66 torezolid phosphate 66 phase IIb 66 Spiegelmer ® 66 NADiA ProsVue 66 Prodarsan 66 Phase 1a clinical 66 investigational humanized monoclonal antibody 66 Phase lll 66 SILENOR 66 GALNS 66 confirmatory Phase III 66 ATL# [001] 66 Panzem 66 zileuton CR 66 RIGScan 65 XOMA 3AB 65 CR# vcMMAE 65 AMPAKINE CX# 65 nalbuphine ER 65 rALLy clinical trial 65 Phase IIIb clinical 65 oral methylnaltrexone 65 Nasulin 65 elotuzumab 65 CCX# 65 OvaRex R 65 Omigard 65 Phase 2b trial 65 Stimuvax R 65 R#/MEM # 65 oral ridaforolimus 65 immunotherapeutic vaccine 65 velafermin belinostat 65 Voraxaze 65 preclinical efficacy 65 Memryte 65 phase IIb study 65 ruxolitinib 65 AEG# 65 Menerba 65 OvaRex ® MAb 65 apricitabine ATC 65 PEG SN# 65 Alzhemed TM 65 PREOS 65 Cloretazine ® 65 Phase Ib 65 Bicifadine 65 Fodosine 65 anticancer compound 65 ADVANCE PD 64 Phase IIa clinical trials 64 TKM Ebola 64 PHX# 64 HCV protease inhibitor 64 NP2 Enkephalin 64 Phase IIB 64 ONCONASE R 64 GED aPC 64 Icatibant 64 CRD5 64 pradefovir 64 Urocidin 64 Plicera 64 Aganocide 64 Hedgehog antagonist 64 Phase 1b trial 64 Premarket Approval PMA 64 Corlux 64 Hematide ™ 64 RIGScan CR 64 Archexin 64 JZP 64 phase Ib 64 phase IIa 64 CCR9 antagonist 64 rPA anthrax vaccine 64 generation URAT1 inhibitor 64 PREOS R 64 Camvia 64 pharmacokinetic PK study 64 PNP inhibitor 64 rindopepimut 64 forodesine 64 VitiGam 64 PSMA ADC 64 BrachySil TM 64 glucokinase activator 64 trastuzumab DM1 T DM1 64 CoFactor 64 CEQ# 64 Zybrestat 64 Phase #/#a 64 FOLOTYN ® 64 Trofex 64 budesonide foam 64 SinuNase ™ 64 alvespimycin 64 Fx #A 64 nonclinical studies 64 triphendiol 64 Factor VIIa 64 Onconase 64 Anthim 64 ganetespib 64 Orathecin 64 clinical pharmacology studies 64 CBLC# 64 MAXY VII 64 Prodarsan R 64 vilazodone 64 BRIM3 64 VALSTAR 64 MAXY alpha 64 dirucotide 64 investigational HCV polymerase 64 Myocet 64 tiapamil 64 Personalized Immunotherapy 64 Phase Ia 64 registrational trial 63 CIP TRAMADOL ER 63 Pre IND 63 TLK# 63 Zenvia ™ 63 Phase #b/#a trial 63 SNT MC# 63 PRT# 63 FDA approvable letter 63 Cand5 63 TBC# 63 Phase Ib clinical 63 Angiocept 63 ALN PCS 63 BrachySil 63 ELACYT 63 pharmacokinetic studies 63 PROVENGE sipuleucel T 63 Anavex #-# 63 oral taxane 63 candidate REP# 63 Zingo TM 63 Valortim TM 63 Viramidine 63 GLPG# 63 balsalazide tablet 63 PREGNANT Study 63 AERx iDMS 63 Evoltra TM 63 liposomal formulation 63 initiate Phase IIb 63 Onalta ™ 63 Traficet EN 63 Annamycin 63 candidate CRLX# 63 Pimavanserin 63 enzastaurin 63 Biologics License Application BLA 63 ACCLAIM II 63 ENRICH trial 63 Telatinib 63 maribavir 63 LymphoStat B TM 63 JAK inhibitor 63 #D#C# 63 CytoFabTM 63 Phase 2b clinical trials 63 SNS# T 63 Phase 2a 63 AeroLEF TM 63 IRX 2 63 Bioral Amphotericin B 63 SILENOR TM 63 Rhucin R 63 Anturol TM 63 lomitapide 63 PNT# 63 dalbavancin 63 deforolimus 63 Valortim 63 Xcytrin R 63 PRECISE Trial 63 Iluvien ® 63 Azedra 63 Urocortin 2 63 Phase IIb clinical 63 Panzem R 63 phase IIb III 63 Ceflatonin 63 leading oral taxane 63 EndoTAG TM -1 63 unblinding 63 ZEVALIN ® 63 targeted radiotherapeutic 63 T Pred 63 Phase III ADT 63 Phase III Clinical Trial 63 talactoferrin 63 ALN TTR 63 FluCide 63 SparVax TM 63 Shigamabs R 63 Zensana TM 63 BEMA Granisetron 63 brentuximab vedotin SGN 63 Mipomersen 63 Phase IIa clinical 63 Biologics License Application 63 preclinical 63 initiated Phase Ib 63 Zensana 63 AZILECT ® 63 OncoVEX GM CSF 63 LE SN# 63 Phase #b/#a clinical 63 initiate Phase 2b 63 generation purine nucleoside 63 drug GAP #B# 63 Neo Kidney Augment 63 MGN# 63 midstage clinical 62 HCV polymerase inhibitor 62 GLP toxicology 62 romazarit 62 obatoclax 62 teduglutide 62 Novolimus 62 Altastaph 62 budesonide MMX Phase III 62 confirmatory Phase 3 62 Evamist TM 62 VersaFilm 62 Fibrillex TM 62 Investigational 62 tanespimycin 62 IAP inhibitors 62 omacetaxine mepesuccinate 62 CINTREDEKIN BESUDOTOX 62 investigational pan BCR 62 Tarvacin Anti Cancer 62 IMC #B 62 eniluracil 62 Vilazodone 62 ApoB SNALP 62 methylnaltrexone 62 Diamyd ® 62 Guanilib 62 non nucleoside HCV 62 faropenem medoxomil 62 molecular imaging radiopharmaceutical 62 Virulizin R 62 rxRNA 62 MOZOBIL 62 OMAPRO 62 Investigational Device Exemption 62 Japanese Encephalitis vaccine 62 GAP #B# 62 preclinically 62 Biologic License Application BLA 62 OLpur TM H2H 62 Phase IIb 62 liprotamase 62 INS# [001] 62 Phase 1a 62 EOquin 62 Dyloject TM 62 Sym# 62 Androxal TM 62 CB2 selective receptor agonist 62 CRLX# 62 Phase 2b clinical 62 HspE7 62 MAGE A3 ASCI 62 MEK inhibitor RDEA# 62 bardoxolone 62 MEK inhibitor 62 Sulonex 62 HQK 62 Fentanyl Taifun 62 therapeutic monoclonal antibody 62 Q#IR 62 EVIZON TM 62 virus HCV protease inhibitor 62 Cimzia TM 62 CORT # 62 PFO migraine 62 PROSTVAC TM 62 REG2 62 Phase III Pivotal 62 orally dosed 62 Protexia ® 62 Aerosurf 62 INCB# [001] 62 Zemiva TM 62 EGS# 62 rhThrombin 62 PRIMO CABG 62 XmAb 62 FDA Approvable Letter 62 Phase 2a clinical 62 MEND CABG II 62 cystinosis patients 62 including eniluracil ADH 62 Tarvacin TM 62 HepeX B 62 StaphVAX 62 Chemophase 62 ospemifene 62 Troxatyl TM 62 Premarket Approval Application 62 octreotide implant 62 NOX E# 62 seliciclib CYC# 62 Tesetaxel 62 Capesaris 62 PF # [002] 62 rALLy trial 62 MKC# MKC# PP 62 ALN TTR# 62 Phase III Clinical Trials 62 Marketing Authorization Application 62 Zerenex 62 Restanza 62 mertansine 62 RiVax 62 Allovectin 7 R 62 histone deacetylase HDAC inhibitor 62 midstage studies 62 incyclinide 62 Phase III TRIST 62 huC# DM4 62 vosaroxin 62 Allovectin 7 r 62 otelixizumab 62 TOLAMBA 62 TACI Ig 62 StaphVAX R 62 Solorel 62 multicenter Phase 62 brivaracetam 62 Saforis 62 preclinical pharmacokinetic 61 TKM ApoB 61 Aurexis 61 elacytarabine 61 Ruconest 61 Excellagen 61 ONCONASE 61 RAV# 61 cGMP manufacture 61 OraTest 61 Aurora kinase inhibitor 61 Harry Palmin President 61 TOCOSOL Camptothecin 61 alagebrium 61 LEP ETU 61 Curaxin 61 pafuramidine 61 Ozarelix 61 Pivotal Phase III 61 Quinamed 61 INT# [002] 61 Prodarsan ® 61 POSIDUR TM 61 BCX# 61 GRNVAC1 61 Nanobody 61 Cintredekin Besudotox 61 Alvesco R 61 Manja Bouman CEO 61 Phase IIb III 61 compound COTI 61 reslizumab 61 PrevOnco 61 fidaxomicin Phase 3 61 Triolex 61 TKB# 61 Pafuramidine 61 BiTE antibody MT# 61 Oracea TM 61 Solazed 61 Phase III clinical 61 ongoing Phase 1b 61 ALN VSP 61 MBP# [001] 61 Orazol 61 Hematide ™ peginesatide 61 PEG PAL 61 CLIRS trial 61 Lixivaptan 61 pexiganan 61 Phase 1b clinical trials 61 Lisofylline LSF 61 Phase 1b 61 subcutaneous formulation 61 Vicinium TM 61 Veronate 61 crofelemer 61 IND CTA 61 antibody MAb 61 PrevOnco ™ 61 ARISE Phase III 61 BEMA TM Fentanyl 61 indibulin 61 HuCAL antibodies 61 AQ4N 61 TELINTRA 61 trastuzumab DM1 61 APF# NDA 61 omega interferon 61 Onco TCS 61 vivo toxicology 61 RSD# oral 61 acyclovir Lauriad R 61 Lucanix R 61 KNS # 61 Luveniq 61 orBec 61 REG1 61 Curaxin CBLC# 61 VitiGam TM 61 SURFAXIN 61 Phenoptin 61 SEPET TM 61 thymalfasin 61 HCV polymerase 61 successfully commercialize Iluvien 61 MAXY G# 61 MOR# 61 recurrent herpes labialis 61 Desmoteplase 61 PA# [002] 61 Glybera R 61 NEUMUNE 61 ASONEP 61 Lymphoseek ® 61 motexafin gadolinium Injection 61 Protexia R 61 FavId 61 compound INCB# 61 Azedra TM 61 BioNumerik 61 Flutiform ™ 61 Proxinium TM 61 APF# 61 DCCR 61 Shigamabs ® 61 PEARL SC 61 tezampanel NGX# 61 nucleotide analog 61 indiplon capsules 61 Atu# 61 inhaled formulation 61 trodusquemine 61 Velcade bortezomib 61 vidofludimus 61 RhuDex 61 QTinno TM 61 MORAb 61 Zenvia Phase III 61 NeuVax 61 ZFP Therapeutic 61 PRECISE trial 61 selective androgen receptor modulator 61 ANAVEX #-# [003] 61 PS# DARA 61 IL# PE#QQR 61 Tarmogen 61 PXD# 61 Onalta 61 PDUFA date 61 epigenetic therapies 61 YONDELIS 61 Neo Kidney Augment ™ 61 CAMPATH 61 Technosphere Insulin 61 SYCREST 61 atacicept 61 E1 INT TM 61 XP# XP# 61 Amigal 61 RSD# 61 HuMax CD4 61 sumatriptan DosePro 61 inhaled AAT 61 clinical trials 61 Ceplene TM 61 MyVax personalized immunotherapy 61 OHR/AVR# 61 initiate Phase 1b 61 Tarceva TM 61 BRILINTA 61 isavuconazole 61 HCD# [002] 61 Bezielle 61 L BLP# 61 Chimigen TM 61 oral PTH 61 lorvotuzumab mertansine 61 XL# SAR# 60 Ketotransdel 60 multicenter Phase II 60 ridaforolimus 60 Actimmune ® 60 NEUGENE R 60 granted Ortec 60 immatics 60 Loramyc R 60 OFIRMEV 60 Ceplene histamine dihydrochloride 60 vascular disrupting agent 60 LungExpress Dx TM 60 eTag assays 60 ThermoDox R 60 Unit Dose Budesonide 60 CCR5 antagonist 60 ZK EPO 60 preclinical studies 60 Phase #/#a trial 60 personalized immunotherapy 60 ATL/TV# 60 Phase 2b Clinical Trial 60 AZILECT R 60 prostone 60 APEX PD 60 DAVANAT ® 60 PDX pralatrexate 60 histamine dihydrochloride 60 dose cohort 60 HuMax EGFr 60 naronapride 60 Proellex TM 60 Ron Bentsur 60 OMAPRO ™ 60 StemEx R 60 oxymorphone ER 60 bicifadine 60 UVIDEM 60 Urokinase 60 ZEGERID Capsules 60 Somatuline R Autogel R 60 CTCE 60 ponatinib 60 AAG geldanamycin analog 60 phase Ib clinical 60 autologous cellular immunotherapy 60 Cethromycin 60 Phase Ib clinical trials 60 Augment Injectable 60 DR Cysteamine 60 SAR# [002] 60 RNAi Therapeutic 60 HGS ETR1 60 Aplidin 60 tramiprosate Alzhemed TM 60 TRO# 60 DOS# 60 tolevamer 60 relapsed MCL 60 Stedivaze 60 Rhucin ® 60 GRN# 60 Lupuzor 60 Tectin TM 60 tremelimumab 60 Homspera 60 L DOS# 60 alogliptin 60 file INDs 60 recombinant biopharmaceutical 60 Complete Response 60 Omapro 60 IIa trials 60 torezolid 60 URG# 60 ACAPODENE 60 PDE# inhibitors 60 EndoTAG TM 60 Phase III registrational 60 Elagolix 60 Trizytek 60 romidepsin novel 60 Phase III 60 Marqibo TM 60 Varespladib 60 Fentanyl TAIFUN R 60 Oglemilast 60 WILEX 60 Viprinex TM 60 rALLy 60 faropenem 60 Octreotide 60 Cardio Vascu Grow 60 tasimelteon 60 sterile lidocaine patch 60 IMGN# 60 Eniluracil 60 tramiprosate ALZHEMED TM 60 INDs 60 Oracea 60 phase 2a 60 lintuzumab SGN 60 basal insulin analogue 60 dacetuzumab 60 BNC# 60 Teflaro 60 OMNARIS Nasal Spray 60 RGB # 60 Pruvel 60 adrenergic regulation 60 Virulizin ® 60 Marketing Authorization Application MAA 60 GeoVax vaccine 60 TOCOSOL 60 zanolimumab 60 TRANSDUR Bupivacaine 60 pivotal Phase III 60 Alferon N 60 OvaDx 60 Aganocide ® 60 siRNA therapeutics 60 Testosterone MDTS ® 60 Marqibo 60 Hematide TM 60 OncoGel 60 dosing cohort 60 IND Filing 60 plasma kallikrein inhibitor 60 FACTIVE R gemifloxacin 60 LidoPAIN SP 60 ofatumumab HuMax CD# 60 MGCD# [001] 60 AZD# TC 60 H#N# VLP vaccine 60 EOquin TM 60 Phase III confirmatory 60 Urocidin TM 60 Phase III clinical trials 60 Files Investigational 60 AMD# [003] 60 pharmacokinetic PK 60 GLP1 agonist 60 HDL Selective Delipidation 60 Phase IIb trial 60 apoptosis inducer 60 Prostate AdenoCarcinoma Treatment 60 oral salmon calcitonin 60 ATL# [002] 60 MONOVISC 60 ALGRX 60 PCK# 60 Market Approval PMA 60 ISTODAX 60 tezampanel 60 optimal dosing regimens 60 HDL Mimetic Peptide 60 Sulonex TM 60 SMT C# 60 TRIST study 60 multiple ascending dose 60 HuLuc# 60 PS# [001] 60 Phase III HEAT 60 SILENOR ™ 60 alemtuzumab Campath 60 Ostarine 60 APTIVUS 60 systemically administered 60 DermaVir Patch 60 AIMM trial 60 Phase III trials 60 NVA# 60 Neo Urinary Conduit 60 ularitide 60 M Enoxaparin 60 IMVAMUNE R 60 placebo controlled Phase 60 PROVENGE ® 60 OncoVEX 60 JAK2 inhibitor 60 elagolix 60 JOULFERON 60 Clavis Pharma 60 ATPace TM 60 Davanat 60 zileuton IV 60 ChronVac C R 60 Study #CL# 60 PhG alpha 1 60 ENTEREG ® 60 proprietary transdermal patch 60 Degarelix 60 R#/MEM 60 Alocrest 60 OXi# 60 Application BLA 60 mesylate tablets 59 riociguat 59 volociximab 59 THR beta agonist 59 Investigational Device Exemption IDE 59 Intarcia 59 cancer immunotherapies 59 Submits Response 59 Phase IIA 59 Dalbavancin 59 darinaparsin 59 TKM PLK1 59 ZaBeCor 59 TEMSO 59 adecatumumab MT# 59 ThGRF 59 Nanobody ® 59 tafamidis 59 QNEXA ® 59 Initiates Clinical 59 lintuzumab 59 candidate TNFerade biologic 59 TRIOLEX 59 Apoptone 59 Frova ® 59 FluINsure 59 Lovaxin C 59 Opterone 59 Cytolin 59 CDP# 59 Excellarate 59 opioid induced bowel dysfunction 59 CytoFab 59 Sular formulation 59 EGEN 59 HIV integrase inhibitors 59 multi kinase inhibitor 59 iclaprim 59 Ceflatonin R 59 Aganocide R 59 vemurafenib 59 PROSTASCINT R 59 Insegia 59 Initiate Phase 59 HCV nucleoside polymerase inhibitors 59 recombinant polyclonal antibody 59 XmAb# 59 Huntexil 59 CIP ISOTRETINOIN 59 LEVADEX ™ 59 mitogen activated ERK kinase 59 Locteron ® 59 Genasense ® oblimersen 59 ILUVIEN ® 59 PROGENSA R 59 Zemiva ™ 59 SparVax ™ 59 CORLUX 59 ofatumumab 59 KRN# 59 CCR5 mAb 59 MyVax R 59 Medidur TM FA 59 dose escalation Phase 59 Nanobody R 59 sitaxsentan 59 Tyzeka Sebivo 59 NYSE Amex PTN 59 Completes Patient Enrollment 59 pomalidomide 59 lead Aganocide compound 59 SCIB1 59 intranasal formulation 59 UPLYSO 59 MyVax ® 59 HepaGam B 59 tubulin inhibitor 59 QRxPharma 59 Kamada AAT 59 NASDAQ CXSP announced 59 Emezine 59 alvimopan 59 Asentar 59 ChronVac C ® 59 Phase 2b 59 Prednisporin TM 59 mapatumumab 59 CD# CEA 59 OMP #R# 59 randomized controlled Phase 59 Nuvion 59 Triapine R 59 Viprinex 59 Soliris TM eculizumab 59 rBChE 59 epothilone 59 AP# [003] 59 novel peptides 59 ANTEGREN 59 Injectable Suspension 59 PEGPH# 59 investigational therapies 59 ISO Vorin TM 59 HepeX B TM 59 radiation sensitizer 59 omiganan 59 intravenous acetaminophen 59 rilonacept 59 Preos 59 OMP #M# 59 Ereska 59 VQD 59 maturation inhibitor 59 Optiquel ™ 59 thalidomide Thalomid 59 Oxytrex TM 59 pharmacological chaperone 59 Celator 59 acyclovir Lauriad ® 59 human microdosing 59 LAF# 59 Genasense oblimersen sodium Injection 59 BRIM2 59 novel histone deacetylase 59 dextofisopam 59 Rhucin ® recombinant 59 PRX # 59 Aflibercept 59 Preotact 59 fidaxomicin Phase 59 Marketing Authorisation Application 59 FM VP4 59 Kahalalide F 59 isoform selective 59 Intravail R 59 ARIKACE ™ 59 Ascend Therapeutics 59 MGd 59 PROCHYMAL 59 Radilex 59 Kevetrin ™ 59 Dextofisopam 59 APTIMA HPV assay 59 AzaSite Plus 59 bioequivalency 59 Lpathomab 59 oral picoplatin 59 candidate deforolimus 59 TNFerade TM 59 Amrubicin 59 IIb clinical trial 59 anticancer agent 59 Dacogen injection 59 Aryplase 59 ALN HTT 59 Pivotal Phase 59 Ophena TM 59 Oncotype DX colon cancer 59 celgosivir 59 Polymer Microspheres 59 IMPACT IMmunotherapy 59 MYDICAR 59 Spiro Rombotis President 59 EP #R 59 IIa clinical 59 TMC# [002] 59 metaglidasen 59 Hepatitis C HCV 59 Perflubutane Polymer Microspheres 59 farletuzumab 59 Voraxaze ™ 59 Vicriviroc 59 IV acetaminophen 59 ulimorelin 59 Neuradiab 59 Plenaxis TM 59 EDEMA3 trial 59 orally bioavailable 59 CHMP recommendation 59 Pertuzumab 59 rEV# 59 Valortim R 59 Actilon 59 depsipeptide 59 generation calcineurin inhibitor 59 Cinryze ™ 59 NN# [001] 59 LymphoStat B 59 Spiegelmer 59 refractory APL 59 Azedra ™ 59 Kiadis Pharma 59 Sphingomab TM 59 CALAA 59 glufosfamide 59 outlicensed 59 RNAi therapeutic targeting 59 HEPLISAV ™ 59 oral anticancer 59 Enjuvia 59 SAR# [004] 59 nitric oxide donating prostaglandin 59 NEUGENE 59 VNP#M 59 Tasimelteon 59 Phase IIb Trial 59 XL# XL# 59 seasonal influenza VLP vaccine 59 Drug Submission 59 Dr. Fahar Merchant 59 Inc. Amex SYI 59 Relovair 59 Thorough QT 59 recombinant factor VIIa 59 ATIR 59 Panzem R NCD 59 CINQUIL 59 CBLB# 59 Immunotherapeutic 59 ELND# 59 cMET 59 SPL# Gel vaginal microbicide 59 Evoltra ® 59 DB# [003] 59 ARIKACE 59 BiTE antibody 59 lorcaserin NDA 59 Trofex TM 59 Tyrima 59 P2V TM 59 APEX AMI trial 59 Elestrin TM 59 severe hypercholesterolemia 59 Targretin capsules 59 lesinurad 59 novel oral anticoagulant 58 QLT# 58 GLP1 INT TM 58 ixabepilone 58 Presents Preclinical Data 58 RhuDex ® 58 EDEMA3 58 evaluating mipomersen 58 ATryn ® 58 Safinamide 58 tamibarotene 58 Flutiform TM 58 Begins Dosing 58 MEND CABG 58 HGS ETR2 58 next generation URAT1 58 Soliris eculizumab 58 Exelbine NDA 58 Firazyr